Transaction · 0001695028-26-000006

Piscitelli Dominic

Piscitelli Dominic, CFO, reported a transaction classified as exercise at Oric Pharmaceuticals, Inc. involving 52000.000000 shares for an estimated $226720.00. Reported holdings after the transaction were 121828.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCFO
ORICOric Pharmaceuticals, Inc.
Filing timeAug 28
Trade dateAug 26, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

ORIC price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ORIC since 2026-08-28Filed 6 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001695028-26-000006
Common Stock
Transaction date
Aug 26, 2026
Filed Aug 28, 2026, 08:11 PM · 2d delay
Shares
52.0k sh
$436 per share
Estimated value
$22.6M
Computed from shares × price
Holdings after
121k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Includes 1,680 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.

  2. F2

    The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026.

  3. F3

    25% of the shares subject to the option vested on February 1, 2024, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.

Original filing · 0001695028-26-000006
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ORIC